Scopus BioPharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Scopus BioPharma generated cash of -$8,126,628, which is more than the previous year. Cash used in financing activities reached the amount of $241,942 last year. Net change in cash is therefore -$7,818,396.
Cash Flow
| 2018 | -747.31K | 0 | 597.63K |
|---|---|---|---|
| 2019 | -2.12M | -4.25K | 2.18M |
| 2020 | -2.52M | 0 | 4.35M |
| 2021 | -11.42M | -1.99K | 17.55M |
| 2022 | -8.12M | -1.55K | 241.94K |
SCPS Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 7.94M | 1.83M | 36.74K | 1.66K | 158.21K |
Operating activities | |||||
Net income | -11.71M | -26.95M | -10.86M | -2.68M | -685.96K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.72K | 1.5K | 1.44K | 664 | 0 |
Stock-based compensation expense | 351.72K | 669.60K | 290.40K | 213.64K | 0 |
| Deferred income tax benefit | 351.72K | 669.60K | 290.40K | 213.64K | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 3.00B | 2.94B | 1.18M | 0 | 0 |
Cash generated by operating activities | -8.12M | -11.42M | -2.52M | -2.12M | -747.31K |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.55K | -1.99K | 0 | -4.25K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.55K | -1.99K | 0 | -4.25K | 0 |
Financing activities | |||||
Common Stock Issued | 0 | 20.1M | 3.27M | 1.77M | 538.48K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -104.50K | -2.18M | 0 | 0 |
Cash used in financing activities | 241.94K | 17.55M | 4.35M | 2.18M | 597.63K |
Net Change In Cash | -7.81M | 6.11M | 1.79M | 35.08K | -156.55K |
Cash at end of period | 124.57K | 7.94M | 1.83M | 36.74K | 1.66K |
| Data source | Data source | Data source |